Nirogacestat Dihydrobromide and its Impurities
Nirogacestat dihydrobromide is an oral gamma-secretase inhibitor indicated for adults with progressing desmoid tumors, acting by suppressing Notch signaling to inhibit tumor growth and improve clinical outcomes. Reference standards of Nirogacestat Dihydrobromide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
(S)-2-(((S)-8-Chloro-6-fluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide dihydrobromide
(S)-2-(((S)-8-Chloro-6-fluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide dihydrobromide
Catalogue No.:PA 14 1641000
CAS :
2869169-64-0
Molecular Formula : C27H43Br2ClFN5O
Molecular Weight : 667.93
